Viatris Inc (VTRS) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Total Revenue Chart for Viatris Inc
Viatris Inc (VTRS) revenue for FY2025 was USD 14.3B, a -3.0% change from FY2024. Viatris Inc's revenue grew from USD 80.8M in 1985 to USD 14.3B in 2025 (17597.9% over 40 years). Earnings per share grew from USD 0.92 in 2016 to USD 1.71 in 2022 (85.1%). Revenue compound annual growth rate: 5-year CAGR of 3.7%, 10-year CAGR of 4.3%, 20-year CAGR of 12.9%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $18.64B
- Implied Share Price
- $16.23
- Enterprise Value
- $30.77B
- Revenue (TTM)
- $14.74B
- EBITDA
- $4.29B
- Profit Margin
- -2.79%
- Trailing P/E
- —
- Forward P/E
- 6.49
- Price/Book (MRQ)
- 1.31
- Price/Sales (TTM)
- 1.26
- EV/EBITDA
- 11.74
- EV/Revenue
- 2.09
- Dividend Yield
- 2.99%
- Book Value
- $12.59
- Free Cash Flow (FY2025)
- $1.94B
- Free Cash Flow Yield
- 10.39%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.